title: GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
authors.forename: L
authors.initials: L
authors.lastname: Annino
authors.forename: M L
authors.initials: ML
authors.lastname: Vegna
authors.forename: A
authors.initials: A
authors.lastname: Camera
authors.forename: S
authors.initials: S
authors.lastname: Ciolli
authors.forename: W
authors.initials: W
authors.lastname: Deplano
authors.forename: F
authors.initials: F
authors.lastname: Fabiano
authors.forename: F
authors.initials: F
authors.lastname: Ferrara
authors.forename: S
authors.initials: S
authors.lastname: Ladogana
authors.forename: G
authors.initials: G
authors.lastname: Muti
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D002985:Clinical Protocols; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D011379:Prognosis; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin